Post-approval studies (Phase 4)Looking for participantsNCT07301008
What this trial is testing
Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
Who this might be right for
MigraineTrigger Induced Migraine
Medstar Health Research Institute 60